New Zealand markets closed

Rua Bioscience Limited (RUA.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
0.0780-0.0010 (-1.27%)
At close: 03:26PM NZDT
Currency in NZD

Valuation measures4

Market cap (intra-day) 12.33M
Enterprise value 10.00M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)40.14
Price/book (mrq)1.30
Enterprise value/revenue 32.07
Enterprise value/EBITDA -0.85

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-60.61%
S&P500 52-week change 329.57%
52-week high 30.2000
52-week low 30.0720
50-day moving average 30.0897
200-day moving average 30.1174

Share statistics

Avg vol (3-month) 337.28k
Avg vol (10-day) 355.09k
Shares outstanding 5158.14M
Implied shares outstanding 6158.14M
Float 884.47M
% held by insiders 148.07%
% held by institutions 17.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,641.03%

Management effectiveness

Return on assets (ttm)-34.65%
Return on equity (ttm)-96.93%

Income statement

Revenue (ttm)568.58k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-41.40%
Gross profit (ttm)N/A
EBITDA -10.29M
Net income avi to common (ttm)-17.53M
Diluted EPS (ttm)-0.1100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.5M
Total cash per share (mrq)0.02
Total debt (mrq)167.69k
Total debt/equity (mrq)1.77%
Current ratio (mrq)11.25
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-4.39M
Levered free cash flow (ttm)-9.11M